Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Gross Margin (2020 - 2026)

Sotera Health has reported Gross Margin over the past 6 years, most recently at 54.68% for Q4 2025.

  • For Q4 2025, Gross Margin fell 196.0% year-over-year to 54.68%; the TTM value through Dec 2025 reached 55.48%, up 74.0%, while the annual FY2025 figure was 55.48%, 74.0% up from the prior year.
  • Gross Margin for Q4 2025 was 54.68% at Sotera Health, down from 57.04% in the prior quarter.
  • Over five years, Gross Margin peaked at 58.05% in Q4 2023 and troughed at 50.55% in Q1 2023.
  • A 5-year average of 55.15% and a median of 55.41% in 2023 define the central range for Gross Margin.
  • On a YoY basis, Gross Margin climbed as much as 310bps in 2021 and fell as far as -116242bps in 2021.
  • Year by year, Gross Margin stood at 55.52% in 2021, then rose by 1bps to 56.33% in 2022, then grew by 3bps to 58.05% in 2023, then decreased by -2bps to 56.64% in 2024, then fell by -3bps to 54.68% in 2025.
  • Business Quant data shows Gross Margin for SHC at 54.68% in Q4 2025, 57.04% in Q3 2025, and 56.61% in Q2 2025.